Tatiana Kovaleva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tatiana Kovaleva has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Irina Vasilievna Mukhina
Privolzhsky Research Medical University
2 shared publications - I. V. Predeina
Privolzhsky Research Medical University
1 shared publication - Liudmila Matskova
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden
1 shared publication - M. Yu. Skorkina
Institute of Fundamental Medicine, Privolzhsky Research Medical University, 10/1 Minin Sq., Nizhniy Novgorod 603005, Russia
1 shared publication - Murat R. Gainullin
Oslo University Hospital, N-0424 Oslo, Norway
1 shared publication - Nikita Smirnov
Institute of Fundamental Medicine, Privolzhsky Research Medical University, 10/1 Minin Sq., Nizhniy Novgorod 603005, Russia
1 shared publication
Latest Publications
- Open Access
- 29 October 2025
- Published by MDPI AG in Preprints.org
Pax6 as a Therapeutic Target: Convergent Molecular Pathways in the Regulation of Aniridia, Neurogenesis, Neurodegeneration and Oncology
The transcription factor Pax6 acts as a molecular switch regulating various phases of the cell cycle during the early stages of embryonic neurogenesis and serves as a molecular mediator integrating multiple signaling pathways involved in the development of pathophysiological conditions. In this regard, Pax6 is considered an attractive molecular target for developing new drugs aimed at combating neurodegeneration, oncology, and aniridia. The aim of this review is to examine the range of studies describing various Pax6-dependent molecular pathways to identify similarities and differences in the signaling cascades activated by Pax6 in health and disease. These insights may provide a basis for developing new therapeutic strategies targeting Pax6 as a molecular regulator. This review summarizes the data indicating the leading regulatory role of Pax6 in the neuronal cell cycle in health and pathology. It is possible that Pax6 may act as a therapeutic target in certain pathophysiological conditions; however, the effectiveness of such a strategy will depend on the substrate chain in the signaling pathway, its branching, and the redundancy of mediators involved.
- 29 October 2025
- Published by MDPI AG in Preprints.org
Open AccessPax6 as a Therapeutic Target: Convergent Molecular Pathways in the Regulation of Aniridia, Neurogenesis, Neurodegeneration and Oncology
The transcription factor Pax6 acts as a molecular switch regulating various phases of the cell cycle during the early stages of embryonic neurogenesis and serves as a molecular mediator integrating multiple signaling pathways involved in the development of pathophysiological conditions. In this regard, Pax6 is considered an attractive molecular target for developing new drugs aimed at combating neurodegeneration, oncology, and aniridia. The aim of this review is to examine the range of studies describing various Pax6-dependent molecular pathways to identify similarities and differences in the signaling cascades activated by Pax6 in health and disease. These insights may provide a basis for developing new therapeutic strategies targeting Pax6 as a molecular regulator. This review summarizes the data indicating the leading regulatory role of Pax6 in the neuronal cell cycle in health and pathology. It is possible that Pax6 may act as a therapeutic target in certain pathophysiological conditions; however, the effectiveness of such a strategy will depend on the substrate chain in the signaling pathway, its branching, and the redundancy of mediators involved.
- Open Access
- 7 February 2025
- Published by MDPI AG in Preprints.org
Cofilin(s) and Mitochondria: Function Beyond Actin Dynamics
ADF/cofilins form a family of small, widely expressed actin-binding proteins, regulating actin dynamics in various cellular and physiological processes in all eukaryotes from yeasts to animals. Changes in the expression of the ADF/cofilin family proteins have been demonstrated under various pathological conditions. The established role for cofilin in migration, invasion, epithelial-mesenchymal transition, apoptosis, radiotherapy and chemotherapy resistance, immune escape, and transcriptional dysregulation in malignant tumors, is explained mainly by its actin modifying activity. Moreover, drugs targeting this activity of cofilin were developed for treatment of cancers. Its multilevel regulation, extremely diverse effects in numerous forms of pathology, and the conflicting data on the functional effects of changes in cofilin expression prompted us here to point to other functions of cofilin, in addition to that of modifying actin, namely, those which affect lipid metabolism and mitochondrial homeostasis. Here, we review recent data on the expression of ADF/cofilin family proteins in various pathologies, account for the mutations and post-translational modifications of these proteins and their functional consequences, dwell on the role of K63-type ubiquitination of cofilin for its involvement in lipid metabolism and mitochondrial homeostasis, point out conflicting data in cofilin research, and describe prospects for future studies of cofilin functions.
- 7 February 2025
- Published by MDPI AG in Preprints.org
Open AccessCofilin(s) and Mitochondria: Function Beyond Actin Dynamics
ADF/cofilins form a family of small, widely expressed actin-binding proteins, regulating actin dynamics in various cellular and physiological processes in all eukaryotes from yeasts to animals. Changes in the expression of the ADF/cofilin family proteins have been demonstrated under various pathological conditions. The established role for cofilin in migration, invasion, epithelial-mesenchymal transition, apoptosis, radiotherapy and chemotherapy resistance, immune escape, and transcriptional dysregulation in malignant tumors, is explained mainly by its actin modifying activity. Moreover, drugs targeting this activity of cofilin were developed for treatment of cancers. Its multilevel regulation, extremely diverse effects in numerous forms of pathology, and the conflicting data on the functional effects of changes in cofilin expression prompted us here to point to other functions of cofilin, in addition to that of modifying actin, namely, those which affect lipid metabolism and mitochondrial homeostasis. Here, we review recent data on the expression of ADF/cofilin family proteins in various pathologies, account for the mutations and post-translational modifications of these proteins and their functional consequences, dwell on the role of K63-type ubiquitination of cofilin for its involvement in lipid metabolism and mitochondrial homeostasis, point out conflicting data in cofilin research, and describe prospects for future studies of cofilin functions.